Circassia Pharmaceuticals Plc Grant of options (3031Q)

TIDMCIR

RNS Number : 3031Q

Circassia Pharmaceuticals Plc

17 October 2019

Grant of options

Oxford, UK - 17 October 2019: Circassia Pharmaceuticals plc ("Circassia" or "the Company"; LSE: CIR), a specialty biopharmaceutical company focused on respiratory disease, announces that it has granted options ("Options") today over 1,630,435 new ordinary shares of 0.08 pence each in the Company ("Ordinary Shares") (representing 0.43% per cent. of the Company's issued share capital) to Jonathan Emms, who was appointed as Chief Operating Officer of the Company on 2 September 2019, under the 2019 Performance Share Plan.

The Options have been granted at a price of 0.08 pence per Ordinary Share, will vest on the third anniversary of the date of grant and are exercisable until the tenth anniversary of the date of grant. Vesting is subject to share price and sales performance conditions.

Contacts

 
 Circassia                                Tel: [phone] 
  Steve Harris, Chief Executive Officer    405560 
  Julien Cotta, Chief Financial Officer 
  Rob Budge, Corporate Communications 
 Peel Hunt (Nominated Adviser and Joint   Tel: +44 (0) 20 
  Broker)                                  7418 8900 
  James Steel / Dr Christopher Golden 
 finnCap (Joint Broker)                   Tel: +44 (0) 20 
  Geoff Nash / Alice Lane                  7220 0500 
 Numis Securities (Joint Broker)          Tel: +44 (0) 20 
  James Black / Freddie Barnfield          7260 1000 
 FTI Consulting                           Tel: +44 (0) 20 
  Simon Conway / Ciara Martin              3727 1000 
 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 
            1.   Details of the person discharging managerial responsibilities 
                  / person closely associated 
      a.         Name                            Jonathan Emms 
                ==============================  ============================================ 
            2.   Reason for the notification 
                ============================================================================ 
            a.   Position/status                 Chief Operating Officer 
                ==============================  ============================================ 
            b.   Initial notification            Initial notification 
                  /Amendment 
                ==============================  ============================================ 
            3.   Details of the issuer, emission allowance market participant, 
                  auction platform, auctioneer or auction monitor 
                ============================================================================ 
            a.   Name                            Circassia Pharmaceuticals plc 
                ==============================  ============================================ 
            b.   LEI                             2138006YAT138TOGA556 
                ==============================  ============================================ 
            4.   Details of the transaction(s): section to be repeated for 
                  (i) each type of instrument; (ii) each type of transaction; 
                  (iii) each date; and (iv) each place where transactions 
                  have been conducted 
                ============================================================================ 
            a.   Description of                  Options over Ordinary shares of 0.08p each. 
                  the 
                  Financial instrument, 
                  type of instrument              GB00BJVD3B28 
                  Identification 
                  code 
                ==============================  ============================================ 
            b.   Nature of the                   Award of share options granted under the 
                  transaction                     2019 Performance Share Plan over Ordinary 
                                                  Shares in Circassia 
                ==============================  ============================================ 
            c.   Price(s) and                     Price(s)     Volume(s) 
                  volume(s)                        GBP0.0008    1,630,435 
                                                               ---------- 
                ==============================  ============================================ 
            d.        Aggregated information 
                        *    Aggregated volume 
                                                              n/a 
 
                        *    Price 
                ==============================  ============================================ 
            e.   Date of the transaction         2019-10-17 
                ==============================  ============================================ 
            f.   Place of the                    Outside a trading venue 
                  transaction 
                ==============================  ============================================ 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

END

DSHBLBDGXXBBGCR

(END) Dow Jones Newswires

October 17, 2019 12:34 ET (16:34 GMT)